| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net (loss) income | NaN | -63,542 | NaN | NaN |
| Deconsolidation charge | NaN | 41,424 | NaN | NaN |
| Non-cash severance charge | NaN | 5,907 | NaN | NaN |
| Depreciation and amortization | NaN | 21,785 | NaN | NaN |
| Charge (credit) for asbestos-related costs, net | NaN | 12,352 | NaN | NaN |
| Deferred income tax (benefit) provision | NaN | -1,211 | NaN | NaN |
| Difference between net periodic pension and other postretirement costs and contributions | NaN | -7,225 | NaN | NaN |
| Stock-based compensation | NaN | 1,351 | NaN | NaN |
| Non-cash (benefit) provisions - net | NaN | 975 | NaN | NaN |
| Sale-leaseback accretion | NaN | 1,253 | NaN | NaN |
| Loss on disposal of assets | NaN | -489 | NaN | NaN |
| Other net | NaN | 743 | NaN | NaN |
| Receivables | NaN | 7,376 | NaN | NaN |
| Inventories | NaN | -7,366 | NaN | NaN |
| Contract assets | NaN | 2,109 | NaN | NaN |
| Other assets | NaN | 107 | NaN | NaN |
| Insurance receivable asbestos | NaN | -19,099 | NaN | NaN |
| Asbestos liability | NaN | -27,753 | NaN | NaN |
| Accounts payable | NaN | 11,378 | NaN | NaN |
| Accrued payrolls and employee benefits | NaN | -3,315 | NaN | NaN |
| Customer-related liabilities | NaN | -7,991 | NaN | NaN |
| Other liabilities | NaN | -199 | NaN | NaN |
| Net cash flows provided by (used in) operating activities | 1,647 | 2,707 | 6,251 | -7,614 |
| Purchases of property, plant and equipment | 3,385 | 2,771 | 2,973 | 3,661 |
| Proceeds from government grants, for purchase of equipment | NaN | 2,547 | NaN | NaN |
| Proceeds from government grants, used for purchase of equipment | NaN | NaN | 1,020 | 323 |
| Deconsolidation of ues-uk cash on hand | NaN | -3,189 | NaN | NaN |
| Proceeds from sale of property, plant and equipment | 10 | -90 | 297 | NaN |
| Purchases of long-term marketable securities | 2 | 36 | 2 | 10 |
| Proceeds from sale of long-term marketable securities | 144 | 165 | 165 | 334 |
| Payment of debt issuance costs | NaN | 0 | 51 | 840 |
| Net cash flows used in investing activities | -3,233 | -4,717 | -1,493 | -3,014 |
| Proceeds from shareholder exercise of warrants | NaN | 1 | 16 | 1 |
| Proceeds from equipment term notes | NaN | 0 | 0 | 13,500 |
| Proceeds from revolving credit facility | 3,041 | 9,706 | 9,599 | 18,332 |
| Payments on revolving credit facility | 1,500 | 8,017 | 8,257 | 25,144 |
| Repayment of debt principal | 1,359 | 4,077 | 1,081 | 1,475 |
| Net cash flows provided by (used in) financing activities | 182 | -2,387 | 226 | 4,374 |
| Effect of exchange rate changes on cash and cash equivalents | -73 | 142 | 29 | 772 |
| Net decrease in cash and cash equivalents | -1,477 | -4,255 | 5,013 | -5,482 |
| Cash and cash equivalents at beginning of period | 10,703 | 14,958 | 15,427 | NaN |
| Cash and cash equivalents at end of period | 9,226 | 10,703 | 14,958 | NaN |
AMPCO PITTSBURGH CORP (AP)
AMPCO PITTSBURGH CORP (AP)